Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Safe Supply Streaming Portfolio Company Safety Strips, Provides Corporate Update (click to learn more) Saturn Oil & Gas Inc. Announces $525 Million Accretive Core-Area Saskatchewan Asset Acquisition (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News DMK Pharmaceuticals Corp DMKPQ

Healthcare
DMK Pharmaceuticals Corporation, formerly Adamis Pharmaceuticals Corporation, is a commercial stage neuro-biotech company. The Company is focused on developing therapies for opioid use disorder (OUD) and other neuro-based conditions. The Company’s commercial products approved by the United States Food and Drug Administration (FDA) include ZIMHI (naloxone) injection for the treatment of opioid... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (PINL:DMKPQ)

DMK Pharmaceuticals Commences Restructuring Proceeding

Newsfile February 2, 2024

DMK Pharmaceuticals Regains Full Rights to Commercialize ZIMHI

GlobeNewswire December 21, 2023

DMK Pharmaceuticals Regains Full Rights from US WorldMeds for SYMJEPI® and Provides Corporate Update

GlobeNewswire November 28, 2023

DMK Pharmaceuticals Reports Third Quarter 2023 Financial Results and Provides Corporate Update

GlobeNewswire November 14, 2023

DMK Pharmaceuticals Announces Presentation of Preclinical Results Comparing Effects of DPI-125 on Opioid Withdrawal Behaviors Versus Standard of Care for Opioid Use Disorder at SfN Neuroscience 2023

GlobeNewswire November 13, 2023

DMK Pharmaceuticals Announces Inducement Option Grant Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire October 30, 2023

DMK Pharmaceuticals Announces Inducement Option Grant Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire October 20, 2023

DMK Pharmaceuticals Restructures Executive Team to Support Next Phase of Growth

GlobeNewswire October 19, 2023

Adamis Pharmaceuticals Changes Name to DMK Pharmaceuticals to Reflect New Strategic Focus

GlobeNewswire September 7, 2023
View More News ››

Opinion & Analysis (PINL:DMKPQ)

Investor Opportunity Arises from Biopharma's Share Price Weakness on Competitor News

Streetwise Reports August 30, 2018

EpiPen Rival Lands Major Partner

Streetwise Reports July 3, 2018
View More Opinion ››

Bullboard Posts (PINL:DMKPQ)

ADMP....all sideways action now

Coin toss time Ya pays yo money and yo takes yo chances.... $1.84 What's it going to be
Iseneschal - August 3, 2023

ADMP .....better get a move on or its all over

No position  Cheers !
Iseneschal - August 3, 2023

ADMP.... runner

On watch
Iseneschal - August 3, 2023

Volume seems way off

How can you have over 65% of shares sell on open market in 3 hours. Big holders must want the heck out of this? Seems like a progressive...
CBalardo - October 18, 2021

still holding this stock

it is stable at these prices and any news should propel this one to the upside,so glta.
coolfooldumbguy - December 16, 2019

added more of this one

it is way oversold,so I am using DCA,dollar cost averaging,for my purchases,buying up small amounts on a daily basis this month until my...
coolfooldumbguy - December 10, 2019
View more Bullboard ››

Interactive Capital Partners Corporation

Interactive Capital Partners Corporation

View More »